Lucentis is a breakthrough treatment that has been proven to stop and even reverse the effects of neovascular (wet) age-related macular degeneration (AMD). Neovascular AMD is a condition in which the eye develops abnormal blood vessels that leak blood and fluid into the eye. The result is scarring and rapid deterioration of the macula which controls central vision. Lucentis works by blocking a chemical called vascular endothelial growth factor (VEGF) to slow or eliminate the growth of these abnormal vessels.
Detecting the Disease
Neovascular AMD can be detected through an examination by your eye doctor. Advanced imaging technology called Optical Coherence Tomography (OCT) can be used to document the severity and progress of the disease. This diagnostic test takes only a few minutes and can be performed at Eye Health Partners. Other methods of detection and monitoring are fluoroscein angiograms (FA) and fundus photos of the retina.
Developing a Treatment
Clinical studies of Lucentis show promising results for patients suffering from this debilitating disease.
- » Up to 40 percent of patients had a significant improvement of at least three more lines (15 letters) on the eye chart
- » 70 percent of patients could see at least one more letter on the eye chart
- » 95 percent of patients had their eyesight stay the same
- » Up to 40 percent of patients achieved vision of 20/40 or better
Treating the Disease
Lucentis is administered through an injection into the posterior chamber of the eye. After administering an anesthetic to numb the eye and using an antiseptic to prevent infection, Lucentis is injected using a very fine needle. Patients usually need a series of treatments over a few months for the best results.
Saving Your Sight
At Eye Health Partners, we believe that sight is one of our most precious gifts. Our retinal team is here to give help and hope to patients who are in danger of losing their vision. Our caring, experienced retina specialists have access to a spectrum of sight-saving treatment options including Lucentis and follow patients’ progress from beginning to end.
As with any medical procedure, side effects may occur. The most common side effects are soreness, redness and small specks in the vision. However, less common but more serious side effects can occur. Our retina team discusses all the benefits and risks of treatment with patients choosing Lucentis.
The specialists at Eye Health Partners are dedicated to providing the latest technologies, including Eylea and Lucentis to treat patients with macular degeneration. They also provide treatments for other retinal diseases such as diabetic retinopathy. To schedule a consultation, visit our contact page to schedule a consultation with one of our Montgomery, Cullman, Columbia, Gadsden, Birmingham, Mobile, Nashville, Murfreesboro, or Oxford-Anniston specialists.